Wunderlich Securities Reiterating a 'Buy' on HCC Insurance Holdings (HCC); Raises PT & Estimates
More News related to HCC
- HCC Announces Intent to Redeem 1.3% Convertible Notes
- HCC Declares 55th Quarterly Dividend
- Health Insurance 2.0 - Cashing in on Social Media
- Fitch Rates HCC's $300MM Sr. Unsecured Notes 'A'; Outlook Stable
- HCC Insurance Holdings, Inc. Announces Pricing of $300 Million Senior Notes Offering
More News related to Analyst Comments
- Green Mountain (GMCR) Will Likely Win Diedrich Coffee (DDRX) Bidding War - Analyst
- FBR Capital Raises Estimates & PT on Trina Solar (TSL) following 3Q09 results
- Broadpoint.AmTech Reiterates a 'Buy' on Precision Castparts (PCP); Issues Top Ten for Owning Shares
- Citi Recommends Stocks in Qatar, UAE, Egypt; Believes Middle East Will 'Catch Up' to Emerging Markets
- Broadpoint.AmTech Maintains a 'Buy' on First Solar (FSLR); Lowers PT and Estimates
Wunderlich Securities reiterating a 'Buy' rating on HCC Insurance Holdings (NYSE: HCC), price target $31.
Wunderlich analyst says, "We are reiterating our Buy recommendation and $31 price target for HCC Insurance. In addition, we are raising our estimates for 3Q09 to $0.70 from $0.67 and our 2009 estimate to $2.95 from $2.75. Our revised estimate is above the company's guidance provided at the beginning of the year of $2.65. We believe HCC is likely to achieve a higher 3Q09 and 2009 operating EPS result due to mild weather and the stable pricing the company has experienced. We believe HCC's superior ratings and diverse product mix offer an excellent platform to gain market share in a difficult underwriting environment."
To see more analyst ratings on HCC Click Here.
HCC Insurance Holdings, Inc., together with its subsidiaries, provides property and casualty, surety, group life, accident, and health insurance coverage, as well as related agency and reinsurance brokerage services to commercial customers and individuals.
Related Categories
Analyst CommentsStocks Mentioned
+0.18Related Entities
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
